TransMedics Group, Inc. (TMDX)
99.05
0.00 (0.00%)

99.05
0.00 (0.00%)
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
| Name | Position |
|---|---|
| Dr. Tamer I. Khayal M.D. | Chief Commercial Officer |
| Dr. Waleed H. Hassanein M.D. | Founder, President, CEO & Director |
| Mr. Anil Ranganath | Advisor |
| Mr. Gerardo Hernandez | CFO & Treasurer |
| Mr. Matthew Forsyth | SVP, General Counsel & Corporate Secretary |
| Mr. Nicholas Corcoran | Senior Vice President of Supply Chain & Operations |
| Ms. Miriam C. Provost Ph.D. | Vice President of Global Regulatory Affairs |
| Date | Type | Document |
|---|---|---|
| 2026-01-12 | 8-K | d25695d8k.htm |
| 2025-10-29 | 10-Q | tmdx-20250930.htm |
| 2025-10-06 | 8-K | d96819d8k.htm |
| 2025-07-30 | 10-Q | tmdx-20250630.htm |
| 2025-05-30 | SD | d26279dsd.htm |
| 2025-05-23 | 8-K | d908250d8k.htm |
| 2025-05-08 | 8-K | tmdx-20250508.htm |
| 2025-04-10 | ARS | d873239dars.pdf |
| 2025-02-27 | 10-K | tmdx-20241231.htm |
| 2025-02-21 | 8-K | d919290d8k.htm |